首页 > 最新文献

Current drug discovery technologies最新文献

英文 中文
Targeting G-Quadruplex DNA for Cancer Chemotherapy. 靶向g -四重体DNA用于癌症化疗
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666220214115408
Sumanta Debbarma, Pratap Chandra Acharya

The self-association of DNA formed by Hoogsteen hydrogen bonding comprises several layers of four guanine or G-tetrads or G4s. The distinct feature of G4s, such as the G-tetrads and loops, qualify structure-selective recognition by small molecules and various ligands and can act as potential anticancer therapeutic molecules. The G4 selective ligands can influence gene expression by targeting a nucleic acid structure rather than sequence. Telomere G4 can be targeted for cancer treatment by small molecules inhibiting the telomerase activity, whereas c-MYC is capable of controlling transcription and can be targeted to influence transcription. The k-RAS is one of the most frequently encountered oncogenic driver mutations in pancreatic, colorectal, and lung cancers. The k-RAS oncogene plays an important role in acquiring and increasing drug resistance and can also be directly targeted by small molecules to combat k-RAS mutant tumors. Modular G4 ligands with different functional groups, side chains, and rotatable bonds, as well as conformation, affect the binding affinity/ selectivity in cancer chemotherapeutic interventions. These modular G4 ligands act by targeting the diversity of G4 loops and groves and assist in developing more drug-like compounds with selectivity. In this review, we present the recent research on synthetic G4 DNA-interacting ligands as an approach towards the discovery of target-specific anticancer chemotherapeutic agents.

由Hoogsteen氢键形成的DNA的自结合包括几层四鸟嘌呤或g -四聚体或G4s。G4s的独特特征,如g四分体和g环,可以被小分子和各种配体进行结构选择性识别,并可以作为潜在的抗癌治疗分子。G4选择性配体可以通过靶向核酸结构而不是序列来影响基因表达。端粒G4可以通过抑制端粒酶活性的小分子靶向治疗癌症,而c-MYC能够控制转录,可以靶向影响转录。k-RAS是胰腺癌、结直肠癌和肺癌中最常见的致癌驱动突变之一。k-RAS癌基因在获得和增加耐药性中起着重要作用,也可以被小分子直接靶向以对抗k-RAS突变肿瘤。具有不同官能团、侧链和可旋转键以及构象的模块化G4配体影响肿瘤化疗干预中的结合亲和力/选择性。这些模块化的G4配体通过靶向G4环和小格罗夫的多样性而起作用,并有助于开发更多具有选择性的类药物化合物。本文综述了近年来合成G4 dna相互作用配体作为发现靶向性抗癌化疗药物的途径的研究进展。
{"title":"Targeting G-Quadruplex DNA for Cancer Chemotherapy.","authors":"Sumanta Debbarma,&nbsp;Pratap Chandra Acharya","doi":"10.2174/1570163819666220214115408","DOIUrl":"https://doi.org/10.2174/1570163819666220214115408","url":null,"abstract":"<p><p>The self-association of DNA formed by Hoogsteen hydrogen bonding comprises several layers of four guanine or G-tetrads or G4s. The distinct feature of G4s, such as the G-tetrads and loops, qualify structure-selective recognition by small molecules and various ligands and can act as potential anticancer therapeutic molecules. The G4 selective ligands can influence gene expression by targeting a nucleic acid structure rather than sequence. Telomere G4 can be targeted for cancer treatment by small molecules inhibiting the telomerase activity, whereas c-MYC is capable of controlling transcription and can be targeted to influence transcription. The k-RAS is one of the most frequently encountered oncogenic driver mutations in pancreatic, colorectal, and lung cancers. The k-RAS oncogene plays an important role in acquiring and increasing drug resistance and can also be directly targeted by small molecules to combat k-RAS mutant tumors. Modular G4 ligands with different functional groups, side chains, and rotatable bonds, as well as conformation, affect the binding affinity/ selectivity in cancer chemotherapeutic interventions. These modular G4 ligands act by targeting the diversity of G4 loops and groves and assist in developing more drug-like compounds with selectivity. In this review, we present the recent research on synthetic G4 DNA-interacting ligands as an approach towards the discovery of target-specific anticancer chemotherapeutic agents.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"19 3","pages":"e140222201110"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39916613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
In Vitro and In Vivo Approaches for Screening the Potential of Anticancer Agents: A Review. 体外和体内筛选抗癌药物潜力的方法:综述。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666220106122811
Rakhi Mishra, Prem Shankar Mishra, Shruti Varshney, Rupa Mazumder, Avijit Mazumder

Background: Anticancer drug development is a tedious process, requiring several in vitro, in vivo, and clinical studies. In order to avoid chemical toxicity in animals during an experiment, it is necessary to envisage toxic doses of screened drugs in vivo at different concentrations. Several in vitro and in vivo studies have been reported to discover the management of cancer.

Materials and methods: This study focused on bringing together a wide range of in vivo and in vitro assay methods developed to evaluate each hallmark feature of cancer.

Result: This review provides detailed information on target-based and cell-based screening of new anticancer drugs in the molecular targeting period. This would help in inciting an alteration from the preclinical screening of pragmatic compound-orientated to target-orientated drug selection.

Conclusion: Selection methodologies for finding anticancer activity have importance for tumor- specific agents. In this study, advanced rationalization of the cell-based assay is explored along with broad applications of the cell-based methodologies considering other opportunities.

背景:抗癌药物的开发是一个繁琐的过程,需要多次体外、体内和临床研究。为了避免在实验中对动物产生化学毒性,有必要设想所筛选药物在不同浓度下的体内毒性剂量。据报道,一些体外和体内研究发现了癌症的管理。材料和方法:本研究的重点是将广泛的体内和体外检测方法结合起来,以评估癌症的每个标志性特征。结果:本文综述了分子靶向时期基于靶点和基于细胞的抗癌新药筛选。这将有助于激发从实用化合物导向的临床前筛选到靶向导向的药物选择的改变。结论:寻找肿瘤特异性药物的抗癌活性的选择方法具有重要意义。在这项研究中,先进的合理化的细胞为基础的分析是探索与广泛应用的细胞为基础的方法考虑到其他机会。
{"title":"In Vitro and In Vivo Approaches for Screening the Potential of Anticancer Agents: A Review.","authors":"Rakhi Mishra,&nbsp;Prem Shankar Mishra,&nbsp;Shruti Varshney,&nbsp;Rupa Mazumder,&nbsp;Avijit Mazumder","doi":"10.2174/1570163819666220106122811","DOIUrl":"https://doi.org/10.2174/1570163819666220106122811","url":null,"abstract":"<p><strong>Background: </strong>Anticancer drug development is a tedious process, requiring several in vitro, in vivo, and clinical studies. In order to avoid chemical toxicity in animals during an experiment, it is necessary to envisage toxic doses of screened drugs in vivo at different concentrations. Several in vitro and in vivo studies have been reported to discover the management of cancer.</p><p><strong>Materials and methods: </strong>This study focused on bringing together a wide range of in vivo and in vitro assay methods developed to evaluate each hallmark feature of cancer.</p><p><strong>Result: </strong>This review provides detailed information on target-based and cell-based screening of new anticancer drugs in the molecular targeting period. This would help in inciting an alteration from the preclinical screening of pragmatic compound-orientated to target-orientated drug selection.</p><p><strong>Conclusion: </strong>Selection methodologies for finding anticancer activity have importance for tumor- specific agents. In this study, advanced rationalization of the cell-based assay is explored along with broad applications of the cell-based methodologies considering other opportunities.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"19 3","pages":"e060122200071"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39792947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Structure-based De Novo Design and Docking Studies of 5(S)-Methyl-L-Proline Containing Peptidomimetic Compounds as Dipeptidyl Peptidase-4 Inhibitors. 5(S)-甲基- l-脯氨酸类拟肽化合物作为二肽基肽酶-4抑制剂的结构设计与对接研究
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666211221100457
Anuradha K Gajjar, Chirag D Pathak

Background: Diabetes affects millions of people worldwide, with predicted numbers of about 700 million adults affected by 2045. Among the several anti-diabetic drug therapies available in the market, Dipeptidyl Peptidase-4 (DPP-4) inhibitors have emerged as a promising therapeutic approach with scope for exploration in the segment of peptidomimetics.

Objective: Series of proline-containing peptidomimetic compounds were designed and investigated for their drug-likeness through Lipinski's rule of five, lead-likeness through the rule of three, predictive pharmacokinetic studies (absorption, distribution, metabolism, and excretion), and toxicity properties through in-silico approaches. The designed compounds were evaluated for their interactions with binding sites of the enzyme DPP-4 using an extra precision docking approach.

Methods: Proline-containing peptidomimetic compounds were designed rationally. Drug-likeness and lead-likeness properties were calculated using Schrödinger Maestro v11.2 software. ADME and toxicity properties were predicted using PreADMET version 2.0. Docking study was performed using Schrödinger Maestro v11.2 software, and ligands for the study were designed using MarvinSketch software.

Results: 5(S)-methyl-L-proline containing 17 ligands were designed. All of them were found to obey Lipinski's rule of five. Compounds were found to have good ADME profile and low toxicity predictions.

Conclusion: Four compounds were found to have good interactions with DPP-4 binding sites and hence created the scope to develop DPP-4 inhibitors containing 5(S)-methyl-L-proline moiety.

背景:全世界有数百万人患有糖尿病,预计到2045年将有7亿成年人患有糖尿病。在市场上可用的几种抗糖尿病药物治疗中,二肽基肽酶-4 (DPP-4)抑制剂已成为一种有前景的治疗方法,在肽模拟物领域有探索的空间。目的:设计了一系列含脯氨酸的拟肽化合物,并通过利平斯基五法则、三法则、预测药代动力学(吸收、分布、代谢和排泄)和计算机方法研究了它们的药物相似性和毒性。设计的化合物使用额外的精确对接方法评估了它们与DPP-4酶结合位点的相互作用。方法:合理设计含脯氨酸的类肽化合物。使用Schrödinger Maestro v11.2软件计算药物相似度和铅相似度。使用PreADMET 2.0版本预测ADME和毒性。对接研究采用Schrödinger Maestro v11.2软件进行,研究配体采用marvinssketch软件设计。结果:设计了含有17个配体的5(S)-甲基- l-脯氨酸。所有的人都遵守利平斯基的五原则。发现化合物具有良好的ADME谱和低毒性预测。结论:发现4个化合物与DPP-4结合位点具有良好的相互作用,从而为开发含有5(S)-甲基- l-脯氨酸片段的DPP-4抑制剂创造了条件。
{"title":"Structure-based De Novo Design and Docking Studies of 5(S)-Methyl-L-Proline Containing Peptidomimetic Compounds as Dipeptidyl Peptidase-4 Inhibitors.","authors":"Anuradha K Gajjar,&nbsp;Chirag D Pathak","doi":"10.2174/1570163819666211221100457","DOIUrl":"https://doi.org/10.2174/1570163819666211221100457","url":null,"abstract":"<p><strong>Background: </strong>Diabetes affects millions of people worldwide, with predicted numbers of about 700 million adults affected by 2045. Among the several anti-diabetic drug therapies available in the market, Dipeptidyl Peptidase-4 (DPP-4) inhibitors have emerged as a promising therapeutic approach with scope for exploration in the segment of peptidomimetics.</p><p><strong>Objective: </strong>Series of proline-containing peptidomimetic compounds were designed and investigated for their drug-likeness through Lipinski's rule of five, lead-likeness through the rule of three, predictive pharmacokinetic studies (absorption, distribution, metabolism, and excretion), and toxicity properties through in-silico approaches. The designed compounds were evaluated for their interactions with binding sites of the enzyme DPP-4 using an extra precision docking approach.</p><p><strong>Methods: </strong>Proline-containing peptidomimetic compounds were designed rationally. Drug-likeness and lead-likeness properties were calculated using Schrödinger Maestro v11.2 software. ADME and toxicity properties were predicted using PreADMET version 2.0. Docking study was performed using Schrödinger Maestro v11.2 software, and ligands for the study were designed using MarvinSketch software.</p><p><strong>Results: </strong>5(S)-methyl-L-proline containing 17 ligands were designed. All of them were found to obey Lipinski's rule of five. Compounds were found to have good ADME profile and low toxicity predictions.</p><p><strong>Conclusion: </strong>Four compounds were found to have good interactions with DPP-4 binding sites and hence created the scope to develop DPP-4 inhibitors containing 5(S)-methyl-L-proline moiety.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"e211221199189"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39611544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Edible Medicinal Plants on Facilitating Childbirth: A Systematic Review. 促进生育的食用药用植物:系统综述。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163818666210924115650
Fatemeh Rahmani Ivari, Atiyeh Mohamadzadeh Vatanchi, Mahdi Yousefi, Fateme Badaksh, Roshanak Salari

Background: Despite advances and the availability of newer drugs to facilitate childbirth, the interest in using natural treatments is on the rise. More than 20 percent of pregnancies require induction of labor, which is associated with side effects and increased risk of cesarean surgery. For this reason, the use of medicinal plants is considered healthier.

Objective: The present study is a systematic review of the role of oral herbs in facilitating childbirth.

Method: This review was conducted via searching the Medline/PubMed, Google Scholar, Scopus, and SID databases. The review began systematically and with no time constraints. It lasted until December 29, 2020.

Results: Twenty clinical trials investigated the impact of edible plants on increasing cervical readiness, stimulating labor onset, reducing pain intensity, and shortening the duration of labor. Five studies have revealed the positive impact of saffron. Two studies reported the same effect by chamomile. Three studies showed the positive impact of boiled dill seeds, and two studies showed the impact of date and date syrup. Another study reported the impact of Descurainia Sophia, and six studies also showed the positive effect of castor oil on uterine stimulation, strengthening and relieving labor pains, which eventually lead to facilitating labor. One study also showed no improvement in bishop score after consumption of primrose capsules.

Conclusion: The positive effect of edible medicinal plants on facilitating childbirth has been shown in the mentioned studies. However, more studies with a larger sample size are needed, and there is also a need for a more detailed study of the possible mechanisms of plant effects.

背景:尽管促进分娩的新药物取得了进展和可用性,但使用自然疗法的兴趣正在上升。超过20%的怀孕需要引产,这与剖宫产手术的副作用和风险增加有关。因此,使用药用植物被认为更健康。目的:本研究是一个系统的回顾作用,口服草药在促进分娩。方法:检索Medline/PubMed、Google Scholar、Scopus和SID数据库。审查工作有条不紊地开始,没有时间限制。它一直持续到2020年12月29日。结果:20项临床试验调查了食用植物对提高宫颈准备度、刺激分娩开始、减轻疼痛强度和缩短分娩时间的影响。五项研究揭示了藏红花的积极作用。两项研究报告了洋甘菊的相同效果。三项研究显示了煮莳萝籽的积极影响,两项研究显示了枣和枣糖浆的影响。另一项研究报道了鸢尾草的影响,还有六项研究也显示了蓖麻油在刺激子宫、加强和缓解阵痛方面的积极作用,最终促进了分娩。一项研究也表明,食用报春花胶囊后,主教评分没有改善。结论:上述研究均证实了食用药用植物对促进分娩的积极作用。然而,还需要更多更大样本量的研究,也需要对植物效应的可能机制进行更详细的研究。
{"title":"Edible Medicinal Plants on Facilitating Childbirth: A Systematic Review.","authors":"Fatemeh Rahmani Ivari,&nbsp;Atiyeh Mohamadzadeh Vatanchi,&nbsp;Mahdi Yousefi,&nbsp;Fateme Badaksh,&nbsp;Roshanak Salari","doi":"10.2174/1570163818666210924115650","DOIUrl":"https://doi.org/10.2174/1570163818666210924115650","url":null,"abstract":"<p><strong>Background: </strong>Despite advances and the availability of newer drugs to facilitate childbirth, the interest in using natural treatments is on the rise. More than 20 percent of pregnancies require induction of labor, which is associated with side effects and increased risk of cesarean surgery. For this reason, the use of medicinal plants is considered healthier.</p><p><strong>Objective: </strong>The present study is a systematic review of the role of oral herbs in facilitating childbirth.</p><p><strong>Method: </strong>This review was conducted via searching the Medline/PubMed, Google Scholar, Scopus, and SID databases. The review began systematically and with no time constraints. It lasted until December 29, 2020.</p><p><strong>Results: </strong>Twenty clinical trials investigated the impact of edible plants on increasing cervical readiness, stimulating labor onset, reducing pain intensity, and shortening the duration of labor. Five studies have revealed the positive impact of saffron. Two studies reported the same effect by chamomile. Three studies showed the positive impact of boiled dill seeds, and two studies showed the impact of date and date syrup. Another study reported the impact of Descurainia Sophia, and six studies also showed the positive effect of castor oil on uterine stimulation, strengthening and relieving labor pains, which eventually lead to facilitating labor. One study also showed no improvement in bishop score after consumption of primrose capsules.</p><p><strong>Conclusion: </strong>The positive effect of edible medicinal plants on facilitating childbirth has been shown in the mentioned studies. However, more studies with a larger sample size are needed, and there is also a need for a more detailed study of the possible mechanisms of plant effects.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"e240921196771"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39450435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
vHTS, 3-D Pharmacophore, QSAR and Molecular Docking Studies for the Identification of Phyto-derived ATP-Competitive Inhibitors of the BCR-ABL Kinase Domain. BCR-ABL激酶结构域植物源性atp竞争性抑制剂的vHTS、3-D药效团、QSAR和分子对接研究。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666211202092632
Damilohun Samuel Metibemu, Oluwatoba Emmanuel Oyeneyin, Ayorinde Omolara Metibemu, Olawole Yakubu Adeniran, Idowu Olaposi Omotuyi

Background: Chronic myelogenous leukaemia (CML) constitutes about 15 % of adult leukaemia and is characterized by the overproduction of immature myeloid cells.

Methods: In this study, a virtual high throughput screening (vHTS) technique was employed to screen a library of phytochemicals of reported plants having anticancer activity. A docking score of -10 kcalmol-1 was used as the cut-off for the selection of phyto-compounds for pharmacophore-based virtual screening. Statistically robust and thoroughly validated QSAR model (R = 0.914, R2 = 0.836, Adjusted R2 = 0.764, LOO-CV= 0.6680) was derived for the inhibition of BCR-ABL kinase domain.

Results: The virtual screening, pharmacophore screening, QSAR model and molecular docking techniques applied herein revealed ellagic acid, a polyphenolic compound, as a potential competitive inhibitor of the BCR-ABL kinase domain. Ellagic acid binds to the inactive ABL state and forms similar interactions with key residues within the BCR-ABL Kinase domain as obtained in ponatinib (having inhibitory effects on the ABL thr-315I mutant). It forms hydrogen bond interaction with thr-315 residue (the gatekeeper residue). It is not likely to be prone to the various mutations associated with nilotinib because of its small size.

Conclusion: The procedure of VHTs, Pharmacophore, QSAR, and molecular docking applied in this study could help in detecting more anti-CML compounds.

背景:慢性髓性白血病(CML)约占成人白血病的15%,其特征是未成熟骨髓细胞的过量产生。方法:采用虚拟高通量筛选(vHTS)技术对已报道的具有抗癌活性的植物化学物质库进行筛选。对接分数-10 kcalmol-1被用作选择植物化合物进行基于药物团的虚拟筛选的截止值。在BCR-ABL激酶结构域的抑制上,建立了具有统计学稳稳性且经过充分验证的QSAR模型(R = 0.914, R2 = 0.836,调整后的R2 = 0.764, lo - cv = 0.6680)。结果:本文应用的虚拟筛选、药效团筛选、QSAR模型和分子对接技术表明,鞣花酸是一种多酚类化合物,是BCR-ABL激酶结构域的潜在竞争性抑制剂。鞣花酸结合无活性的ABL状态,并与BCR-ABL激酶结构域内的关键残基形成类似的相互作用,如ponatinib所获得的(对ABL thr3 - 315i突变体具有抑制作用)。与thr3 -315残基(看门人残基)形成氢键相互作用。它不太可能容易发生与尼罗替尼相关的各种突变,因为它的体积小。结论:本研究采用的vht、药效团、QSAR和分子对接方法有助于检测更多抗cml化合物。
{"title":"vHTS, 3-D Pharmacophore, QSAR and Molecular Docking Studies for the Identification of Phyto-derived ATP-Competitive Inhibitors of the BCR-ABL Kinase Domain.","authors":"Damilohun Samuel Metibemu,&nbsp;Oluwatoba Emmanuel Oyeneyin,&nbsp;Ayorinde Omolara Metibemu,&nbsp;Olawole Yakubu Adeniran,&nbsp;Idowu Olaposi Omotuyi","doi":"10.2174/1570163819666211202092632","DOIUrl":"https://doi.org/10.2174/1570163819666211202092632","url":null,"abstract":"<p><strong>Background: </strong>Chronic myelogenous leukaemia (CML) constitutes about 15 % of adult leukaemia and is characterized by the overproduction of immature myeloid cells.</p><p><strong>Methods: </strong>In this study, a virtual high throughput screening (vHTS) technique was employed to screen a library of phytochemicals of reported plants having anticancer activity. A docking score of -10 kcalmol<sup>-1</sup> was used as the cut-off for the selection of phyto-compounds for pharmacophore-based virtual screening. Statistically robust and thoroughly validated QSAR model (R = 0.914, R<sup>2</sup> = 0.836, Adjusted R<sup>2</sup> = 0.764, LOO-CV= 0.6680) was derived for the inhibition of BCR-ABL kinase domain.</p><p><strong>Results: </strong>The virtual screening, pharmacophore screening, QSAR model and molecular docking techniques applied herein revealed ellagic acid, a polyphenolic compound, as a potential competitive inhibitor of the BCR-ABL kinase domain. Ellagic acid binds to the inactive ABL state and forms similar interactions with key residues within the BCR-ABL Kinase domain as obtained in ponatinib (having inhibitory effects on the ABL thr-315I mutant). It forms hydrogen bond interaction with thr-315 residue (the gatekeeper residue). It is not likely to be prone to the various mutations associated with nilotinib because of its small size.</p><p><strong>Conclusion: </strong>The procedure of VHTs, Pharmacophore, QSAR, and molecular docking applied in this study could help in detecting more anti-CML compounds.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"e021221198480"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39775261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prunella vulgaris L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review. 夏枯草:关键药理、说明性传统用途和广泛的植物化学综述。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163818666210203181542
Reyaz Hassan Mir, Mohammad Faizan Bhat, Gifty Sawhney, Parveen Kumar, Nusrit Iqbal Andrabi, Majeed Shaikh, Roohi Mohi-Ud-Din, Mubashir Hussain Masoodi

Background: Prunella vulgaris , family Lamiaceae also known as self-heal, has been traditionally used as an expectorant, anti-inflammatory, anti-pyretic, and anti-rheumatic. Due to the widespread distribution of the plant, Vulgaris is also called 'vulgar' in Latin adjective meaning common.

Objective: The objective of this review was to describe the relevant aspects of phytochemistry and therapeutic uses of different fractions as well as isolated compounds from Prunella vulgaris . An attempt was also made to enumerate the possible leads, e.g . betulinic acid, oleanolic acid, ursolic acid, umbelliferone, scopoletin, esculetin, luteolin, homoorientin, Rosmarinic acid and cinaroside, for further development.

Method: For peer-reviewed research literature, we undertook a structured search of bibliographic databases using a focused review question. Scientific databases such as PubMed, Scopus, Science Direct, and Google Scholar were searched.

Results: Phytochemistry of Prunella vulgaris (PV) after a thorough literature survey revealed varied and copious metabolites, such as triterpenoids, phenolic acid, sterols, carbohydrates, coumarins, fatty acids, and volatile oils. Many of these compounds have been found to possess a wide range of biological activities per se, including anti-microbial, immunosuppressive, anti-cancer, cardio- protective, anti-allergic and anti-inflammatory activities.

Conclusion: Prunella vulgaris is a medicinal plant of immense medicinal importance having a variety of compounds, such as triterpenoids, phenolic acid, sterols, carbohydrates, coumarins, fatty acids, and volatile oils, and diversity in the pharmacological spectrum. The plant could be further exploited to isolate the various biologically active constituents responsible for its activity.

背景:夏枯草,科也被称为自愈,传统上被用作祛痰,抗炎,解热,抗风湿。由于这种植物分布广泛,Vulgaris在拉丁语形容词中也被称为“庸俗的”,意思是普通的。目的:综述夏枯草不同部位和分离化合物的植物化学及治疗作用。还试图列举可能的线索,例如:白桦酸、齐墩果酸、熊果酸、伞形草酮、东莨菪素、木犀草素、同质草素、迷迭香酸和肉桂苷,用于进一步开发。方法:对于同行评议的研究文献,我们使用重点综述问题对书目数据库进行结构化搜索。研究人员搜索了PubMed、Scopus、Science Direct和Google Scholar等科学数据库。结果:通过对夏枯草的植物化学研究,发现其代谢产物丰富多样,包括三萜、酚酸、甾醇、碳水化合物、香豆素、脂肪酸和挥发油等。其中许多化合物本身具有广泛的生物活性,包括抗微生物、免疫抑制、抗癌、心脏保护、抗过敏和抗炎活性。结论:夏枯草是一种具有丰富药用价值的药用植物,其化学成分包括三萜、酚酸、甾醇、碳水化合物、香豆素、脂肪酸和挥发油等,药理谱多样。该植物可以进一步开发分离其活性的各种生物活性成分。
{"title":"<i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review.","authors":"Reyaz Hassan Mir,&nbsp;Mohammad Faizan Bhat,&nbsp;Gifty Sawhney,&nbsp;Parveen Kumar,&nbsp;Nusrit Iqbal Andrabi,&nbsp;Majeed Shaikh,&nbsp;Roohi Mohi-Ud-Din,&nbsp;Mubashir Hussain Masoodi","doi":"10.2174/1570163818666210203181542","DOIUrl":"https://doi.org/10.2174/1570163818666210203181542","url":null,"abstract":"<p><strong>Background: </strong>Prunella vulgaris , family Lamiaceae also known as self-heal, has been traditionally used as an expectorant, anti-inflammatory, anti-pyretic, and anti-rheumatic. Due to the widespread distribution of the plant, Vulgaris is also called 'vulgar' in Latin adjective meaning common.</p><p><strong>Objective: </strong>The objective of this review was to describe the relevant aspects of phytochemistry and therapeutic uses of different fractions as well as isolated compounds from Prunella vulgaris . An attempt was also made to enumerate the possible leads, e.g . betulinic acid, oleanolic acid, ursolic acid, umbelliferone, scopoletin, esculetin, luteolin, homoorientin, Rosmarinic acid and cinaroside, for further development.</p><p><strong>Method: </strong>For peer-reviewed research literature, we undertook a structured search of bibliographic databases using a focused review question. Scientific databases such as PubMed, Scopus, Science Direct, and Google Scholar were searched.</p><p><strong>Results: </strong>Phytochemistry of Prunella vulgaris (PV) after a thorough literature survey revealed varied and copious metabolites, such as triterpenoids, phenolic acid, sterols, carbohydrates, coumarins, fatty acids, and volatile oils. Many of these compounds have been found to possess a wide range of biological activities per se, including anti-microbial, immunosuppressive, anti-cancer, cardio- protective, anti-allergic and anti-inflammatory activities.</p><p><strong>Conclusion: </strong>Prunella vulgaris is a medicinal plant of immense medicinal importance having a variety of compounds, such as triterpenoids, phenolic acid, sterols, carbohydrates, coumarins, fatty acids, and volatile oils, and diversity in the pharmacological spectrum. The plant could be further exploited to isolate the various biologically active constituents responsible for its activity.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"19 1","pages":"e140122191102"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25330049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Herbal Medicines for Idiopathic Male Infertility: A Systematic Review. 草药治疗特发性男性不育症:系统综述。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666220820122101
Mohammad Ahmadian, Roshanak Salari, Mohammad Reza Noras, Hamid Reza Bahrami-Taghanaki

Background: Various medications, surgeries, and assisted reproductive techniques are used to treat male infertility, but the high cost and low effectiveness have made these methods unpopular. The use of herbal medicines such as Withania somnifera, Ceratonia siliqua, Nigella sativa and Alpinia officinarum for the treatment of male infertility has become highly popular in recent years.

Objective: We conducted this systematic review to evaluate the recent scientific evidence regarding herbal medicines used to treat idiopathic male infertility (IMI).

Methods: Online literature resources were checked using different search engines, including ISI, Web of Knowledge, Medline, PubMed, Scopus, and Google Scholar. Date restrictions were applied to 2020, and the publication language was restricted to English and Persian. The risk of bias was evaluated using the Cochrane method.

Results: Out of 851 articles, 14 trials with 1218 participants were included. Of the 15 plants and medicinal products introduced in the selected studies, 12 cases were effective in treating male infertility. Each of these plants or products affects specific components of male fertility for which various mechanisms were mentioned, but most of them had antioxidant effects. No serious side effects were reported.

Conclusion: Whitania somnifera roots, Alpinia officinarum, Nigella sativa seeds, Tomato, and Ceratonia siliqua and the formulation of Xperm, PHF, Churna Ratnam, Svaguptadi Churna, Y virilin capsule, manix capsule, and Tradafertil tablet revealed successful outcomes in treatment of idiopathic male infertility.

背景:各种药物、手术和辅助生殖技术被用于治疗男性不育症,但这些方法的高成本和低效果使这些方法不受欢迎。近年来,人们普遍使用一些草药治疗男性不育症,如Withania somnifera、Ceratonia siliqua、Nigella sativa和Alpinia officinarum。目的:我们进行了这一系统综述,以评估最近关于草药治疗特发性男性不育症(IMI)的科学证据。方法:利用ISI、Web of Knowledge、Medline、PubMed、Scopus、Google Scholar等搜索引擎对网络文献资源进行检索。日期限制适用于2020年,出版语言仅限于英语和波斯语。采用Cochrane方法评估偏倚风险。结果:在851篇文章中,纳入了14项试验,1218名受试者。在选定的研究中介绍的15种植物和药品中,有12例对治疗男性不育症有效。这些植物或产品中的每一种都影响男性生育能力的特定成分,其中各种机制被提到,但大多数都具有抗氧化作用。没有严重的副作用报告。结论:黑穗槐根、高山麻、黑穗槐种子、番茄、白屈菌及Xperm、PHF、chillna Ratnam、saguptadi Churna、yvirilin胶囊、manix胶囊、Tradafertil片治疗特发男性不育症疗效显著。
{"title":"Herbal Medicines for Idiopathic Male Infertility: A Systematic Review.","authors":"Mohammad Ahmadian,&nbsp;Roshanak Salari,&nbsp;Mohammad Reza Noras,&nbsp;Hamid Reza Bahrami-Taghanaki","doi":"10.2174/1570163819666220820122101","DOIUrl":"https://doi.org/10.2174/1570163819666220820122101","url":null,"abstract":"<p><strong>Background: </strong>Various medications, surgeries, and assisted reproductive techniques are used to treat male infertility, but the high cost and low effectiveness have made these methods unpopular. The use of herbal medicines such as Withania somnifera, Ceratonia siliqua, Nigella sativa and Alpinia officinarum for the treatment of male infertility has become highly popular in recent years.</p><p><strong>Objective: </strong>We conducted this systematic review to evaluate the recent scientific evidence regarding herbal medicines used to treat idiopathic male infertility (IMI).</p><p><strong>Methods: </strong>Online literature resources were checked using different search engines, including ISI, Web of Knowledge, Medline, PubMed, Scopus, and Google Scholar. Date restrictions were applied to 2020, and the publication language was restricted to English and Persian. The risk of bias was evaluated using the Cochrane method.</p><p><strong>Results: </strong>Out of 851 articles, 14 trials with 1218 participants were included. Of the 15 plants and medicinal products introduced in the selected studies, 12 cases were effective in treating male infertility. Each of these plants or products affects specific components of male fertility for which various mechanisms were mentioned, but most of them had antioxidant effects. No serious side effects were reported.</p><p><strong>Conclusion: </strong>Whitania somnifera roots, Alpinia officinarum, Nigella sativa seeds, Tomato, and Ceratonia siliqua and the formulation of Xperm, PHF, Churna Ratnam, Svaguptadi Churna, Y virilin capsule, manix capsule, and Tradafertil tablet revealed successful outcomes in treatment of idiopathic male infertility.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"19 6","pages":"e200822207800"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10620934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Fatty Acid Biosynthesis: An Updated Review on KAS Inhibitors. 脂肪酸生物合成:KAS抑制剂的最新进展。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666220111113032
Rani Shinde, Vasanti Suvarna

Since the early twentieth century, with the isolation of penicillin and streptomycin in the 1940s, the modern era of anti-infective drug development has gained momentum. Due to the enormous success of early drug discovery, many infectious diseases were successfully prevented and eradicated. However, this initial hope was wrongheaded, and pathogens evolved as a significant threat to human health. Drug resistance develops as a result of natural selection's relentless pressure, necessitating the identification of new drug targets and the creation of chemotherapeutics that bypass existing drug resistance mechanisms. Fatty acid biosynthesis (FAS) is a crucial metabolic mechanism for bacteria during their growth and development. Several crucial enzymes involved in this biosynthetic pathway have been identified as potential targets for new antibacterial agents. In Escherichia coli (E. coli), this pathway has been extensively investigated. The present review focuses on progress in the development of Kas A, Kas B, and Fab H inhibitors as mono-therapeutic antibiotics.

自20世纪初以来,随着青霉素和链霉素在20世纪40年代的分离,现代抗感染药物的开发获得了动力。由于早期药物发现的巨大成功,许多传染病被成功地预防和根除。然而,这种最初的希望是错误的,病原体演变成对人类健康的重大威胁。耐药性的产生是自然选择的无情压力的结果,需要确定新的药物靶点,并创造绕过现有耐药机制的化疗药物。脂肪酸生物合成是细菌生长发育过程中重要的代谢机制。参与这一生物合成途径的几个关键酶已被确定为新型抗菌剂的潜在靶点。在大肠杆菌中,这一途径已被广泛研究。现就Kas A、Kas B和Fab H抑制剂作为单药抗生素的研究进展作一综述。
{"title":"Fatty Acid Biosynthesis: An Updated Review on KAS Inhibitors.","authors":"Rani Shinde,&nbsp;Vasanti Suvarna","doi":"10.2174/1570163819666220111113032","DOIUrl":"https://doi.org/10.2174/1570163819666220111113032","url":null,"abstract":"<p><p>Since the early twentieth century, with the isolation of penicillin and streptomycin in the 1940s, the modern era of anti-infective drug development has gained momentum. Due to the enormous success of early drug discovery, many infectious diseases were successfully prevented and eradicated. However, this initial hope was wrongheaded, and pathogens evolved as a significant threat to human health. Drug resistance develops as a result of natural selection's relentless pressure, necessitating the identification of new drug targets and the creation of chemotherapeutics that bypass existing drug resistance mechanisms. Fatty acid biosynthesis (FAS) is a crucial metabolic mechanism for bacteria during their growth and development. Several crucial enzymes involved in this biosynthetic pathway have been identified as potential targets for new antibacterial agents. In Escherichia coli (E. coli), this pathway has been extensively investigated. The present review focuses on progress in the development of Kas A, Kas B, and Fab H inhibitors as mono-therapeutic antibiotics.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"e110122200137"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39814903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparing the Effects of a Herbal Drug based on Echium Amoenum With Fluvoxamine in the Treatment of Adolescents with Obsessive-compulsive Disorder. 阿竹莲与氟伏沙明治疗青少年强迫症的疗效比较。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666220624093416
Mohamad Reza Noras, Atefeh Soltanifar, Roshanak Salari, Lida Jarahi, Maryam Hosseini Abrishami

Background: Obsessive-compulsive disorder (OCD) is a severe and debilitating neuropsychiatric condition. Although selective serotonin reuptake inhibitors, tricyclic antidepressants, and cognitive- behavioral therapy are the first-line medication and treatment for OCD, an estimated 30% of patients are treatment-resistant, and complete functional recovery is rare. Natural products as adjuvant or alternative therapies should be examined to find safer and more effective ways to manage OCD.

Objectives: To investigate the potential benefits of a combined herbal drug based on Echium amoenum in treating OCD.

Methods: Design and Setting: In the psychiatric clinics of Mashhad University of Medical Sciences, 40 patients who met the criteria for the obsessive-compulsive disorder based on DSM-5 were studied in a parallel, double-blind, randomized clinical trial.

Intervention: Subjects were randomly assigned to receive Echium amoenum-Melissa officinalis syrup and fluvoxamine or placebo syrup and fluvoxamine for 8 weeks.

Outcome measures: The efficacy of treatment and recurrence of disease were surveyed and compared according to the Yale-Brown Obsessive Compulsive Scale at weeks 0, 4, and 8.

Results: Evaluation at the 4th and 8th week showed no significant differences between the two groups (p-value = 0.11, p-value = 0.445, respectively). At the 8th week of treatment, patients in the intervention group showed a remarkable reduction in scores on the Yale-Brown Obsessive-Compulsive Scale questionnaire (p- value= 0.003), and patients in the control group didn't ((p- value= 0.180). This study showed that the E.amoneum-M.officinalis syrup was not significantly more efficacious than the fluvoxamine tablet, but the intervention group showed a significant improving trend (p-value= 0.001).

Conclusion: While monotherapy is usually the gold standard methodology, combination or augmentation therapy may also be of merit. Consequently, studies with larger sample sizes and the inclusion of para-clinical assessments such as serologic tests can further shed light on the mechanism of action of the E. amoneum- M. officinalis syrup and deepen our understanding of its effects.

背景:强迫症(OCD)是一种严重且衰弱的神经精神疾病。虽然选择性5 -羟色胺再摄取抑制剂、三环抗抑郁药和认知行为疗法是强迫症的一线药物和治疗方法,但估计有30%的患者对治疗有抗药性,完全恢复功能的患者很少。应该研究天然产品作为辅助或替代疗法,以找到更安全、更有效的方法来治疗强迫症。目的:探讨以紫锥菊为基础的复方中药治疗强迫症的潜在疗效。方法:设计与设置:在马什哈德医科大学精神科诊所,对40例符合DSM-5强迫症诊断标准的患者进行平行、双盲、随机临床试验。干预:受试者被随机分配服用阿莫西莲-梅利莎糖浆和氟伏沙明或安慰剂糖浆和氟伏沙明,为期8周。结果测量:在第0周、第4周和第8周,根据耶鲁-布朗强迫症量表对治疗效果和疾病复发进行调查和比较。结果:两组患者第4、8周评分差异无统计学意义(p值分别为0.11、0.445)。治疗第8周时,干预组患者耶鲁-布朗强迫症量表得分显著降低(p值= 0.003),对照组患者无显著降低(p值= 0.180)。本研究表明,E.amoneum-M。Officinalis syrup与氟伏沙明片疗效无显著性差异,但干预组有显著改善趋势(p值= 0.001)。结论:虽然单药治疗通常是金标准方法,但联合治疗或强化治疗也可能有价值。因此,更大样本量的研究和包括临床评估,如血清学测试,可以进一步阐明金合欢- officinalis糖浆的作用机制,加深我们对其作用的理解。
{"title":"Comparing the Effects of a Herbal Drug based on <i>Echium Amoenum</i> With Fluvoxamine in the Treatment of Adolescents with Obsessive-compulsive Disorder.","authors":"Mohamad Reza Noras,&nbsp;Atefeh Soltanifar,&nbsp;Roshanak Salari,&nbsp;Lida Jarahi,&nbsp;Maryam Hosseini Abrishami","doi":"10.2174/1570163819666220624093416","DOIUrl":"https://doi.org/10.2174/1570163819666220624093416","url":null,"abstract":"<p><strong>Background: </strong>Obsessive-compulsive disorder (OCD) is a severe and debilitating neuropsychiatric condition. Although selective serotonin reuptake inhibitors, tricyclic antidepressants, and cognitive- behavioral therapy are the first-line medication and treatment for OCD, an estimated 30% of patients are treatment-resistant, and complete functional recovery is rare. Natural products as adjuvant or alternative therapies should be examined to find safer and more effective ways to manage OCD.</p><p><strong>Objectives: </strong>To investigate the potential benefits of a combined herbal drug based on Echium amoenum in treating OCD.</p><p><strong>Methods: </strong>Design and Setting: In the psychiatric clinics of Mashhad University of Medical Sciences, 40 patients who met the criteria for the obsessive-compulsive disorder based on DSM-5 were studied in a parallel, double-blind, randomized clinical trial.</p><p><strong>Intervention: </strong>Subjects were randomly assigned to receive Echium amoenum-Melissa officinalis syrup and fluvoxamine or placebo syrup and fluvoxamine for 8 weeks.</p><p><strong>Outcome measures: </strong>The efficacy of treatment and recurrence of disease were surveyed and compared according to the Yale-Brown Obsessive Compulsive Scale at weeks 0, 4, and 8.</p><p><strong>Results: </strong>Evaluation at the 4th and 8th week showed no significant differences between the two groups (p-value = 0.11, p-value = 0.445, respectively). At the 8th week of treatment, patients in the intervention group showed a remarkable reduction in scores on the Yale-Brown Obsessive-Compulsive Scale questionnaire (p- value= 0.003), and patients in the control group didn't ((p- value= 0.180). This study showed that the E.amoneum-M.officinalis syrup was not significantly more efficacious than the fluvoxamine tablet, but the intervention group showed a significant improving trend (p-value= 0.001).</p><p><strong>Conclusion: </strong>While monotherapy is usually the gold standard methodology, combination or augmentation therapy may also be of merit. Consequently, studies with larger sample sizes and the inclusion of para-clinical assessments such as serologic tests can further shed light on the mechanism of action of the E. amoneum- M. officinalis syrup and deepen our understanding of its effects.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"e240622206368"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40395768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structure-Based Drug Design and Development of Novel Synthetic Compounds with Anti-Viral Property against SARS-COV-2. 基于结构的抗SARS-COV-2新型合成化合物的药物设计与开发
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.2174/1570163819666220128145724
Reshma Tendulkar, Aasma Chouhan, Avika Gupta, Aaliya Chaudhary, Chandani Dubey, Sushil Shukla

Background: The world is suffering from health and economic devastation due to the coronavirus disease-2019 (COVID-19) pandemic. Given the number of people affected and also the death rate, the virus is definitely a serious threat to humanity. The novel replication mechanism of the coronavirus is likely well understood, similar to prior studies on the severe acute respiratory syndrome (SARS-CoV-2) virus.

Objective: The antiviral activity of various compounds of the flavonoid class was checked against SARS-COVID-19 using diverse tools and software.

Methods: From the flavonoid compound class, 100 synthetic compounds with potential antiviral activity were selected and improved for screening and induced fit docking, which was reduced to 25 compounds with good docking scores and docking energies. In addition to the apparent match of the molecule with the shape of the binding pocket, a full analysis of the non-covalent interactions in the active site was assessed.

Results: Compounds nol26, fla37-fl40, an32, an39 showed a maximum docking score, which shows essential interactions for a tight bond. Now, all compounds are synthetic with beneficial drug-like properties.

Conclusion: During the docking study, an increased lipophilic interaction of compounds due to the presence of chlorine in nol26, fla37-fl40, an32, an39 was discovered. fla37-fla40 can be investigated as lead molecules against SARS-COV-2 in futuristic drug development.

背景:由于冠状病毒病-2019 (COVID-19)大流行,世界正在遭受健康和经济破坏。考虑到受感染的人数和死亡率,这种病毒绝对是对人类的严重威胁。与之前对严重急性呼吸综合征(SARS-CoV-2)病毒的研究类似,这种新型冠状病毒的复制机制可能已经得到了很好的理解。目的:利用多种工具和软件检测不同类黄酮类化合物对SARS-COVID-19的抗病毒活性。方法:从类黄酮化合物中筛选出100个具有潜在抗病毒活性的人工合成化合物进行筛选和诱导匹配对接,最终减少到对接分数和对接能较好的25个化合物。除了分子与结合袋形状的明显匹配外,还对活性位点的非共价相互作用进行了全面分析。结果:化合物nol26、fl37 -fl40、an32、和39的对接分数最高,显示了紧密键的必要相互作用。现在,所有的化合物都是具有有益的药物性质的合成物。结论:在对接研究中,发现在nol26、fl37 -fl40、fl32和fl39中由于氯的存在,化合物的亲脂性相互作用增加。在未来的药物开发中,fla37-fla40可作为抗SARS-COV-2的先导分子进行研究。
{"title":"Structure-Based Drug Design and Development of Novel Synthetic Compounds with Anti-Viral Property against SARS-COV-2.","authors":"Reshma Tendulkar,&nbsp;Aasma Chouhan,&nbsp;Avika Gupta,&nbsp;Aaliya Chaudhary,&nbsp;Chandani Dubey,&nbsp;Sushil Shukla","doi":"10.2174/1570163819666220128145724","DOIUrl":"https://doi.org/10.2174/1570163819666220128145724","url":null,"abstract":"<p><strong>Background: </strong>The world is suffering from health and economic devastation due to the coronavirus disease-2019 (COVID-19) pandemic. Given the number of people affected and also the death rate, the virus is definitely a serious threat to humanity. The novel replication mechanism of the coronavirus is likely well understood, similar to prior studies on the severe acute respiratory syndrome (SARS-CoV-2) virus.</p><p><strong>Objective: </strong>The antiviral activity of various compounds of the flavonoid class was checked against SARS-COVID-19 using diverse tools and software.</p><p><strong>Methods: </strong>From the flavonoid compound class, 100 synthetic compounds with potential antiviral activity were selected and improved for screening and induced fit docking, which was reduced to 25 compounds with good docking scores and docking energies. In addition to the apparent match of the molecule with the shape of the binding pocket, a full analysis of the non-covalent interactions in the active site was assessed.</p><p><strong>Results: </strong>Compounds nol26, fla37-fl40, an32, an39 showed a maximum docking score, which shows essential interactions for a tight bond. Now, all compounds are synthetic with beneficial drug-like properties.</p><p><strong>Conclusion: </strong>During the docking study, an increased lipophilic interaction of compounds due to the presence of chlorine in nol26, fla37-fl40, an32, an39 was discovered. fla37-fla40 can be investigated as lead molecules against SARS-COV-2 in futuristic drug development.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"19 4","pages":"e280122200663"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39743449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Current drug discovery technologies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1